Article
Identification and validation of a novel signature as a diagnostic and prognostic biomarker in colorectal cancer
2 Nov 2022
Abstract excerpt
BACKGROUND: Colorectal cancer (CRC) is one of the most common malignant neoplasms worldwide. Although marker genes associated with CRC have been identified previously, only a few have fulfilled the therapeutic demand. Therefore, based on differentially expressed genes (DEGs), this study aimed to establish a promising and valuable signature model to diagnose CRC and predict patient's prognosis. METHODS: The key...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
